Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Emily Poles
Prevalence and Predictors of Androgen Receptor and Programmed Death-Ligand 1 in BRCA1-associated and Sporadic Triple-Negative Breast Cancer
npj Breast Cancer
Oncology
Radiology
Nuclear Medicine
Pharmacology
Imaging
Related publications
Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Androgen Receptor-Positive, Triple-Negative Breast Cancer
Cancer
Cancer Research
Oncology
Expression of Androgen Receptor and C-Kit (CD117) in Triple Negative Breast Cancer
Immunopathology, Allergology, Infectology
BCL11A Confers Cell Invasion and Migration in Androgen Receptor‑positive Triple‑negative Breast Cancer
Oncology Letters
Cancer Research
Oncology
Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte, Programmed Death Ligand-1 Expression With Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Characterization of the Interactions Between Calmodulin and Death Receptor 5 in Triple-Negative and Estrogen Receptor-Positive Breast Cancer Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Modification of BRCA1-Associated Breast Cancer Risk by the Polymorphic Androgen-Receptor CAG Repeat
American Journal of Human Genetics
Genetics
Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
Clinical Cancer Research
Cancer Research
Oncology
Mesothelin Expression and Survival Outcomes in Triple Receptor Negative Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
